
Kevin M. Johnson
Examiner (ID: 17187)
| Most Active Art Unit | 1793 |
| Art Unit(s) | 1793, 1732 |
| Total Applications | 255 |
| Issued Applications | 85 |
| Pending Applications | 85 |
| Abandoned Applications | 85 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18953431
[patent_doc_number] => 20240041758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE
[patent_app_type] => utility
[patent_app_number] => 18/227463
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18227463
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/227463 | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine | Jul 27, 2023 | Issued |
Array
(
[id] => 19001898
[patent_doc_number] => 20240065969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/359642
[patent_app_country] => US
[patent_app_date] => 2023-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18359642
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/359642 | OPHTHALMIC TOPICAL CREAM FORMULATIONS AND USES THEREOF | Jul 25, 2023 | Pending |
Array
(
[id] => 18769610
[patent_doc_number] => 20230364380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => CATHETER LOCK SOLUTION COMPRISING SODIUM CITRATE AND BENZYL ALCOHOL
[patent_app_type] => utility
[patent_app_number] => 18/356331
[patent_app_country] => US
[patent_app_date] => 2023-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18356331
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/356331 | Catheter lock solution comprising sodium citrate and benzyl alcohol | Jul 20, 2023 | Issued |
Array
(
[id] => 19001971
[patent_doc_number] => 20240066042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE
[patent_app_type] => utility
[patent_app_number] => 18/357004
[patent_app_country] => US
[patent_app_date] => 2023-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18357004
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/357004 | USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE | Jul 20, 2023 | Abandoned |
Array
(
[id] => 20607031
[patent_doc_number] => 12582610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-24
[patent_title] => Lipid-polymer compositions and methods of use
[patent_app_type] => utility
[patent_app_number] => 18/223187
[patent_app_country] => US
[patent_app_date] => 2023-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15111
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18223187
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/223187 | Lipid-polymer compositions and methods of use | Jul 17, 2023 | Issued |
Array
(
[id] => 19331373
[patent_doc_number] => 20240245803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => NANOPARTICLE AND USE THEREOF FOR THE COMBINATORIAL THERAPY OF ENDOPLASMIC RETICULUM STRESS INDUCER AND IMMUNOTHERAPEUTIC TO TUMORS AND IMMUNE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/353723
[patent_app_country] => US
[patent_app_date] => 2023-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18353723
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/353723 | NANOPARTICLE AND USE THEREOF FOR THE COMBINATORIAL THERAPY OF ENDOPLASMIC RETICULUM STRESS INDUCER AND IMMUNOTHERAPEUTIC TO TUMORS AND IMMUNE CELLS | Jul 16, 2023 | Pending |
Array
(
[id] => 18752418
[patent_doc_number] => 20230355661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/222690
[patent_app_country] => US
[patent_app_date] => 2023-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18222690
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/222690 | Bi-functional co-polymer use for ophthalmic and other topical and local applications | Jul 16, 2023 | Issued |
Array
(
[id] => 19423719
[patent_doc_number] => 12083110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Nicotine lozenge
[patent_app_type] => utility
[patent_app_number] => 18/344198
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 24
[patent_no_of_words] => 8404
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18344198
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/344198 | Nicotine lozenge | Jun 28, 2023 | Issued |
Array
(
[id] => 18675241
[patent_doc_number] => 20230312837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => POLYMERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/208029
[patent_app_country] => US
[patent_app_date] => 2023-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208029 | POLYMERS AND USES THEREOF | Jun 8, 2023 | Pending |
Array
(
[id] => 19120086
[patent_doc_number] => 11964047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Ophthalmic formulations and related methods
[patent_app_type] => utility
[patent_app_number] => 18/207367
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19034
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18207367
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/207367 | Ophthalmic formulations and related methods | Jun 7, 2023 | Issued |
Array
(
[id] => 19225509
[patent_doc_number] => 12005139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Ophthalmic formulations and related methods
[patent_app_type] => utility
[patent_app_number] => 18/207339
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18996
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18207339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/207339 | Ophthalmic formulations and related methods | Jun 7, 2023 | Issued |
Array
(
[id] => 19318313
[patent_doc_number] => 20240239856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => COMPOSITIONS, FORMULATIONS AND INTERLEUKIN PRODUCTION AND PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 18/331093
[patent_app_country] => US
[patent_app_date] => 2023-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18331093
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/331093 | COMPOSITIONS, FORMULATIONS AND INTERLEUKIN PRODUCTION AND PURIFICATION | Jun 6, 2023 | Abandoned |
Array
(
[id] => 19279814
[patent_doc_number] => 20240216286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => NANOSPHERE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/204780
[patent_app_country] => US
[patent_app_date] => 2023-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18204780
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/204780 | NANOSPHERE AND USE THEREOF | May 31, 2023 | Pending |
Array
(
[id] => 18690835
[patent_doc_number] => 20230320992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => SEQUENTIAL ADMINISTRATION OF PARTITIONED ABSORPTION ASPIRIN OR ACTIVE ASPIRIN DERIVATIVE AND COX-2 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/203429
[patent_app_country] => US
[patent_app_date] => 2023-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18203429
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/203429 | SEQUENTIAL ADMINISTRATION OF PARTITIONED ABSORPTION ASPIRIN OR ACTIVE ASPIRIN DERIVATIVE AND COX-2 INHIBITOR | May 29, 2023 | Pending |
Array
(
[id] => 19599398
[patent_doc_number] => 20240390278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => PROCESS FOR MAKING A SOLVENT-FREE NANODISPERSION FOR FAT-SOLUBLE VITAMINS AND NUTRACEUTICALS
[patent_app_type] => utility
[patent_app_number] => 18/201107
[patent_app_country] => US
[patent_app_date] => 2023-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18201107
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/201107 | PROCESS FOR MAKING A SOLVENT-FREE NANODISPERSION FOR FAT-SOLUBLE VITAMINS AND NUTRACEUTICALS | May 22, 2023 | Pending |
Array
(
[id] => 18869921
[patent_doc_number] => 11857701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
[patent_app_type] => utility
[patent_app_number] => 18/321238
[patent_app_country] => US
[patent_app_date] => 2023-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 7519
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/321238 | Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications | May 21, 2023 | Issued |
| 18/250114 | NANOPARTICLES FOR IMAGING AND THERAPY | Apr 20, 2023 | Pending |
Array
(
[id] => 19032069
[patent_doc_number] => 20240081884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY
[patent_app_type] => utility
[patent_app_number] => 18/299444
[patent_app_country] => US
[patent_app_date] => 2023-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18299444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/299444 | METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY | Apr 11, 2023 | Abandoned |
Array
(
[id] => 18806784
[patent_doc_number] => 20230381115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => Close-packed fibrous dosage form
[patent_app_type] => utility
[patent_app_number] => 18/129026
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18129026
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/129026 | Close-packed fibrous dosage form | Mar 29, 2023 | Abandoned |
Array
(
[id] => 18842557
[patent_doc_number] => 20230404961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES
[patent_app_type] => utility
[patent_app_number] => 18/187165
[patent_app_country] => US
[patent_app_date] => 2023-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18187165
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/187165 | OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES | Mar 20, 2023 | Abandoned |